Campath is indicated for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have failed fludarabine therapy. Determination of the effectiveness of Campath is based on overall response rates. (See CLINICAL STUDIES.) Comparative, randomized trials demonstrating increased survival or clinical benefits such as improvement in disease-related symptoms have not yet been conducted.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of MabCampath (Alemtuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the MabCampath (Alemtuzumab) medicine cost price in India.
The order for MabCampath (Alemtuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Alemtuzumab is used to treat a certain type of leukemia (B-cell chronic lymphocytic leukemia, also known as B-CLL). This medication works by stopping the growth of cancer cells. Alemtuzumab is also used to treat multiple sclerosis
MabCampath (Alemtuzumab) , for intravenous use Initial U.S. Approval: 2017
Generic Name: Alemtuzumab
Available only from a restricted distribution program injectable solution 10mg/mL (Lemtrada; 1.2mL/vial [12mg/1.2mL]) 30mg/mL (Campath; 1mL/vial)
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand MabCampath (Alemtuzumab) on prescription and Import License in Patient's Name only.
For overseas patients, MabCampath (Alemtuzumab) can be made available in Send your enquiry to find MabCampath (Alemtuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For MabCampath (Alemtuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Alemtuzumab Increases CMV Infection Risk For More Details
Alemtuzumab Benefits Persist in Multiple Sclerosis For More Details